Alpha Teknova (TKNO) Asset Writedowns and Impairment (2020 - 2026)

Alpha Teknova's (TKNO) quarterly Asset Writedowns and Impairment came in at $7000.0 in Q1 2026, down 98.4% year-on-year from $437000.0 in Q1 2025, and down 98.47% on a QoQ basis from $458000.0 in Q4 2025.

Alpha Teknova (TKNO) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends

Alpha Teknova (TKNO) has 7 years of Asset Writedowns and Impairment data on file, last reported at $7000.0 in Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment fell 98.4% year-over-year to $7000.0 in Q1 2026; TTM through Mar 2026 was $1.7 million, a 233.0% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 1526.92% from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 stood at $7000.0, down from $458000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for TKNO reached as high as $2.2 million in Q2 2023 and fell as low as -$109000.0 in Q4 2023.
  • Historically, Asset Writedowns and Impairment has averaged $412500.0 across 5 years, with a median of $253000.0 in 2024.
  • Across the five-year window, Asset Writedowns and Impairment slumped 116.44% in 2023 and soared 6142.86% in 2025, its largest moves.
  • Year by year, Asset Writedowns and Impairment stood at $663000.0 in 2022, then slumped by 116.44% to -$109000.0 in 2023, then jumped by 163.3% to $69000.0 in 2024, then surged by 563.77% to $458000.0 in 2025, then sank by 98.47% to $7000.0 in 2026.
  • Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $7000.0 in Q1 2026, $458000.0 in Q4 2025, and $732000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Alpha Teknova 278.75 Mn 260.97 Mn 3.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7,000.00
Mar 31, 2026 7,000.00
Dec 31, 2025 458,000.00
Dec 31, 2025 458,000.00
Sep 30, 2025 732,000.00
Sep 30, 2025 732,000.00
Jun 30, 2025 488,000.00
Jun 30, 2025 488,000.00
Mar 31, 2025 437,000.00
Mar 31, 2025 437,000.00
Dec 31, 2024 69,000.00
Dec 31, 2024 69,000.00
Mar 31, 2024 7,000.00
Mar 31, 2024 7,000.00
Dec 31, 2023 -109,000.00
Dec 31, 2023 -109,000.00
Jun 30, 2023 2.20 Mn
Jun 30, 2023 2.20 Mn
Mar 31, 2023 2,000.00
Mar 31, 2023 2,000.00